Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Executive Interview: Gitte Aabo On Leo Pharma's Innovation Strategy

Executive Summary

The head of Denmark's multinational specialty dermatology company has unveiled a strategy to the year 2025 that includes a large increase in R&D spending, a continued interest in bulking up its established products business, and improving its commercial presence in Latin America and other markets.


Related Content

Deal Watch: LEO Pharma Expands Market Reach Through Bayer Dermatology Deal
AstraZeneca Hands LEO Dermatology Potential
Executive Interview: Leo's Gitte Aabo Talks New Products, Business Change


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts